

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.37131985 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.66599231 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.66599231 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.42484000 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.40056429 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.33467145 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 5.22971819 |
| 8 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.14198152 |
| 9 | respiratory electron transport chain (GO:0022904) | 5.13140615 |
| 10 | vocalization behavior (GO:0071625) | 5.10791159 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.04854284 |
| 12 | electron transport chain (GO:0022900) | 5.02348665 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.94441853 |
| 14 | synaptic vesicle maturation (GO:0016188) | 4.87332893 |
| 15 | protein localization to synapse (GO:0035418) | 4.84507443 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.71963474 |
| 17 | ribosomal small subunit biogenesis (GO:0042274) | 4.68359597 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.67314254 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.66512731 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53636629 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.46197817 |
| 22 | glutamate secretion (GO:0014047) | 4.45998757 |
| 23 | proteasome assembly (GO:0043248) | 4.43291719 |
| 24 | axonemal dynein complex assembly (GO:0070286) | 4.31454587 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.28779403 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.26702962 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.26173523 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.23801919 |
| 29 | protein neddylation (GO:0045116) | 4.21100793 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.20717599 |
| 31 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.19108468 |
| 32 | synaptic transmission, dopaminergic (GO:0001963) | 4.10112902 |
| 33 | viral transcription (GO:0019083) | 4.08464974 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.08271199 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.07014910 |
| 36 | protein complex biogenesis (GO:0070271) | 4.05077440 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 4.04654805 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.04627056 |
| 39 | neuronal action potential propagation (GO:0019227) | 4.03972460 |
| 40 | protein targeting to mitochondrion (GO:0006626) | 4.02175032 |
| 41 | purine nucleotide salvage (GO:0032261) | 4.00055814 |
| 42 | regulation of synaptic vesicle transport (GO:1902803) | 3.98935262 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.96967534 |
| 44 | maturation of SSU-rRNA (GO:0030490) | 3.96416661 |
| 45 | protein targeting to ER (GO:0045047) | 3.91909911 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 3.90775017 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.90382159 |
| 48 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.90137895 |
| 49 | regulation of synapse structural plasticity (GO:0051823) | 3.88455558 |
| 50 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.87488678 |
| 51 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.87488678 |
| 52 | translational termination (GO:0006415) | 3.87480392 |
| 53 | cotranslational protein targeting to membrane (GO:0006613) | 3.85431646 |
| 54 | protein maturation by protein folding (GO:0022417) | 3.84236996 |
| 55 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.81359222 |
| 56 | exploration behavior (GO:0035640) | 3.79953314 |
| 57 | protein localization to endoplasmic reticulum (GO:0070972) | 3.78874148 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.78790769 |
| 59 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.76973001 |
| 60 | negative regulation of ligase activity (GO:0051352) | 3.76973001 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.75970781 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.75868074 |
| 63 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.75445223 |
| 64 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.74059039 |
| 65 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.73630712 |
| 66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.72927806 |
| 67 | behavioral response to cocaine (GO:0048148) | 3.72575443 |
| 68 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71798762 |
| 69 | establishment of protein localization to mitochondrion (GO:0072655) | 3.70820542 |
| 70 | regulation of autophagic vacuole assembly (GO:2000785) | 3.67664371 |
| 71 | hydrogen ion transmembrane transport (GO:1902600) | 3.67219107 |
| 72 | long-term memory (GO:0007616) | 3.67065255 |
| 73 | regulation of mitochondrial translation (GO:0070129) | 3.66322192 |
| 74 | positive regulation of synapse maturation (GO:0090129) | 3.65098450 |
| 75 | translational elongation (GO:0006414) | 3.64671407 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64480022 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.63684711 |
| 78 | regulation of oxidative phosphorylation (GO:0002082) | 3.63157312 |
| 79 | response to histamine (GO:0034776) | 3.62386905 |
| 80 | protein localization to mitochondrion (GO:0070585) | 3.61384859 |
| 81 | striatum development (GO:0021756) | 3.60974595 |
| 82 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.59877253 |
| 83 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.59115914 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.59115914 |
| 85 | behavioral fear response (GO:0001662) | 3.58636316 |
| 86 | behavioral defense response (GO:0002209) | 3.58636316 |
| 87 | long-term synaptic potentiation (GO:0060291) | 3.56469145 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.54655405 |
| 89 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.53735542 |
| 90 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.53735542 |
| 91 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53696524 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.52700535 |
| 93 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.52687612 |
| 94 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.52687612 |
| 95 | NADH dehydrogenase complex assembly (GO:0010257) | 3.52687612 |
| 96 | ribosomal large subunit biogenesis (GO:0042273) | 3.51872903 |
| 97 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.51845960 |
| 98 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.50863801 |
| 99 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.50863801 |
| 100 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.50863801 |
| 101 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.50723069 |
| 102 | ribosomal small subunit assembly (GO:0000028) | 3.49052546 |
| 103 | prepulse inhibition (GO:0060134) | 3.47534146 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.46938388 |
| 105 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.46378264 |
| 106 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.46378264 |
| 107 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.44563721 |
| 108 | ATP biosynthetic process (GO:0006754) | 3.43317676 |
| 109 | regulation of synaptic plasticity (GO:0048167) | 3.42062201 |
| 110 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.41877905 |
| 111 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.41877905 |
| 112 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41391239 |
| 113 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41391239 |
| 114 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.40111355 |
| 115 | translation (GO:0006412) | 3.39060884 |
| 116 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.39030233 |
| 117 | GDP-mannose metabolic process (GO:0019673) | 3.38770206 |
| 118 | synaptic vesicle endocytosis (GO:0048488) | 3.37774907 |
| 119 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.35848112 |
| 120 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.32904039 |
| 121 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.32493346 |
| 122 | fear response (GO:0042596) | 3.31991335 |
| 123 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.31359522 |
| 124 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.30279684 |
| 125 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.30176813 |
| 126 | GTP biosynthetic process (GO:0006183) | 3.29958003 |
| 127 | regulation of cellular amine metabolic process (GO:0033238) | 3.28690134 |
| 128 | transmission of nerve impulse (GO:0019226) | 3.27980871 |
| 129 | presynaptic membrane assembly (GO:0097105) | 3.26702085 |
| 130 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.26663496 |
| 131 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.26112336 |
| 132 | viral life cycle (GO:0019058) | 3.25474598 |
| 133 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.24957820 |
| 134 | regulation of neurotransmitter secretion (GO:0046928) | 3.24344038 |
| 135 | neurotransmitter transport (GO:0006836) | 3.23296829 |
| 136 | cullin deneddylation (GO:0010388) | 3.22496098 |
| 137 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.22134625 |
| 138 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.21294349 |
| 139 | auditory behavior (GO:0031223) | 3.21077440 |
| 140 | positive regulation of ligase activity (GO:0051351) | 3.20412734 |
| 141 | proton transport (GO:0015992) | 3.18129662 |
| 142 | rRNA modification (GO:0000154) | 3.17598357 |
| 143 | cellular component biogenesis (GO:0044085) | 3.15314816 |
| 144 | regulation of neurotransmitter transport (GO:0051588) | 3.14474956 |
| 145 | hydrogen transport (GO:0006818) | 3.13694203 |
| 146 | postsynaptic membrane organization (GO:0001941) | 3.13410471 |
| 147 | protein deneddylation (GO:0000338) | 3.12940808 |
| 148 | membrane hyperpolarization (GO:0060081) | 3.12806570 |
| 149 | oxidative phosphorylation (GO:0006119) | 3.12360678 |
| 150 | gamma-aminobutyric acid transport (GO:0015812) | 3.12074643 |
| 151 | cellular protein complex disassembly (GO:0043624) | 3.11669576 |
| 152 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10425618 |
| 153 | layer formation in cerebral cortex (GO:0021819) | 3.10304678 |
| 154 | response to amphetamine (GO:0001975) | 3.10205026 |
| 155 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.09517208 |
| 156 | regulation of glutamate secretion (GO:0014048) | 3.06426437 |
| 157 | translational initiation (GO:0006413) | 3.06315266 |
| 158 | regulation of vacuole organization (GO:0044088) | 3.06297598 |
| 159 | learning (GO:0007612) | 3.05726305 |
| 160 | dendritic spine morphogenesis (GO:0060997) | 3.03567275 |
| 161 | neuromuscular process controlling balance (GO:0050885) | 3.03204588 |
| 162 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.02116073 |
| 163 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02080948 |
| 164 | presynaptic membrane organization (GO:0097090) | 3.02036100 |
| 165 | membrane depolarization (GO:0051899) | 3.01939962 |
| 166 | cytochrome complex assembly (GO:0017004) | 3.01524423 |
| 167 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.01463825 |
| 168 | regulation of neurotransmitter uptake (GO:0051580) | 3.01395881 |
| 169 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.01141895 |
| 170 | aerobic respiration (GO:0009060) | 3.01000529 |
| 171 | aldehyde catabolic process (GO:0046185) | 3.00603076 |
| 172 | mitochondrial transport (GO:0006839) | 3.00578799 |
| 173 | regulation of neurotransmitter levels (GO:0001505) | 3.00295768 |
| 174 | termination of RNA polymerase III transcription (GO:0006386) | 3.00068322 |
| 175 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.00068322 |
| 176 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98177673 |
| 177 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.98029462 |
| 178 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.96809111 |
| 179 | regulation of female receptivity (GO:0045924) | 2.96640283 |
| 180 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.95806663 |
| 181 | respiratory chain complex IV assembly (GO:0008535) | 2.95742882 |
| 182 | negative regulation of dendrite development (GO:2000171) | 2.94909362 |
| 183 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.94578124 |
| 184 | startle response (GO:0001964) | 2.93465219 |
| 185 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.93241260 |
| 186 | positive regulation of synaptic transmission (GO:0050806) | 2.90791908 |
| 187 | mechanosensory behavior (GO:0007638) | 2.90488131 |
| 188 | regulation of vesicle fusion (GO:0031338) | 2.89876503 |
| 189 | dopamine receptor signaling pathway (GO:0007212) | 2.89750042 |
| 190 | response to auditory stimulus (GO:0010996) | 2.88189664 |
| 191 | membrane depolarization during action potential (GO:0086010) | 2.88146173 |
| 192 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87563962 |
| 193 | synaptic transmission (GO:0007268) | 2.85456955 |
| 194 | adult walking behavior (GO:0007628) | 2.83836155 |
| 195 | neuron recognition (GO:0008038) | 2.82001838 |
| 196 | regulation of synapse maturation (GO:0090128) | 2.81834732 |
| 197 | regulation of dendritic spine development (GO:0060998) | 2.81827588 |
| 198 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81127914 |
| 199 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.80922407 |
| 200 | female mating behavior (GO:0060180) | 2.80251888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75131813 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.25109371 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.05631525 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.04415298 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.81975556 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.76569293 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.76046496 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.71334991 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.68607973 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.23407792 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99708421 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.96674559 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.95905496 |
| 14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.91010424 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.85008692 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.78634600 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75896360 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.74087928 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69702098 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64586832 |
| 21 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.54144037 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50980830 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.49488379 |
| 24 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.48465343 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.38436537 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.34094615 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28973459 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.22976459 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.15283373 |
| 30 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13640667 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.10788830 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09723284 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.08538948 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.06255429 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.06255429 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06223513 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05606962 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04669575 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.04155230 |
| 40 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02378409 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.02045553 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98273086 |
| 43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97987296 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93946375 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.93622790 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92394594 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.92367542 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91471507 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89624886 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87866532 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86894442 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85538270 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85326969 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85180239 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.84881203 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84851769 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83427677 |
| 58 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.80814338 |
| 59 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80041613 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79949242 |
| 61 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.79787439 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.78929017 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76129172 |
| 64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.76116032 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75872407 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73190099 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71911380 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71816614 |
| 69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68544328 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64964084 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64323753 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.61333308 |
| 73 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58221029 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57020563 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.56514842 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55655844 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48698801 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47854946 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47350608 |
| 80 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.44831919 |
| 81 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43538514 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42806828 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.41874659 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40799046 |
| 85 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40673225 |
| 86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39770599 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39296302 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37475496 |
| 89 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36866706 |
| 90 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36567734 |
| 91 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36391123 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34024358 |
| 93 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33617736 |
| 94 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33276221 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32113470 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29612323 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28053299 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27596954 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26856557 |
| 100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23922306 |
| 101 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23473784 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22918075 |
| 103 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22816668 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22273808 |
| 105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22214723 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19805342 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19772535 |
| 108 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19377091 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 1.18880120 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18358344 |
| 111 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18324503 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18278397 |
| 113 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18120058 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17821480 |
| 115 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.17681580 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17525401 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16615937 |
| 118 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.16554721 |
| 119 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.15757397 |
| 120 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14890341 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14032780 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13873312 |
| 123 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13769128 |
| 124 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12977770 |
| 125 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12616777 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12506064 |
| 127 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11515258 |
| 128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11376248 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11360218 |
| 130 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10076815 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09350572 |
| 132 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07410372 |
| 133 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06911855 |
| 134 | AR_19668381_ChIP-Seq_PC3_Human | 1.06544225 |
| 135 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06526995 |
| 136 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06436216 |
| 137 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06288031 |
| 138 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06253886 |
| 139 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05714596 |
| 140 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03701327 |
| 141 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03485540 |
| 142 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03270882 |
| 143 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03206637 |
| 144 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03150978 |
| 145 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02974066 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02509338 |
| 147 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02455857 |
| 148 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02206937 |
| 149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01816976 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01770322 |
| 151 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01616606 |
| 152 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01576957 |
| 153 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01545933 |
| 154 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01200610 |
| 155 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01036469 |
| 156 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00820752 |
| 157 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00792291 |
| 158 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98753180 |
| 159 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98548424 |
| 160 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98276085 |
| 161 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98064164 |
| 162 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98009777 |
| 163 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97643784 |
| 164 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97567525 |
| 165 | * P68_20966046_ChIP-Seq_HELA_Human | 0.97370394 |
| 166 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97033491 |
| 167 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96938871 |
| 168 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96348933 |
| 169 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96300731 |
| 170 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95709299 |
| 171 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95144972 |
| 172 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.93786243 |
| 173 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.93584173 |
| 174 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93425352 |
| 175 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93127618 |
| 176 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92286834 |
| 177 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.91697719 |
| 178 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91394567 |
| 179 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91044469 |
| 180 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.90860610 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90496134 |
| 182 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90136538 |
| 183 | MAF_26560356_Chip-Seq_TH2_Human | 0.89908435 |
| 184 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.89225399 |
| 185 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88524978 |
| 186 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88266816 |
| 187 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87484669 |
| 188 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86741548 |
| 189 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86472816 |
| 190 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86260421 |
| 191 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86250890 |
| 192 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86174627 |
| 193 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85851226 |
| 194 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.85842068 |
| 195 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85486699 |
| 196 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85475060 |
| 197 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85087398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.52205810 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.89429620 |
| 3 | MP0003880_abnormal_central_pattern | 4.83315640 |
| 4 | MP0002822_catalepsy | 4.06263582 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.89950572 |
| 6 | MP0009745_abnormal_behavioral_response | 3.43092135 |
| 7 | MP0006036_abnormal_mitochondrial_physio | 3.31562304 |
| 8 | MP0004270_analgesia | 3.30862749 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.28239983 |
| 10 | MP0009046_muscle_twitch | 3.23654233 |
| 11 | MP0009379_abnormal_foot_pigmentation | 3.09330795 |
| 12 | MP0003186_abnormal_redox_activity | 3.02829237 |
| 13 | MP0002064_seizures | 3.02585701 |
| 14 | MP0001968_abnormal_touch/_nociception | 3.02289380 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.75139329 |
| 16 | MP0002272_abnormal_nervous_system | 2.53201603 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.51890516 |
| 18 | MP0002736_abnormal_nociception_after | 2.49210097 |
| 19 | MP0001486_abnormal_startle_reflex | 2.44251380 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.42193358 |
| 21 | MP0001529_abnormal_vocalization | 2.34278106 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.23578270 |
| 23 | MP0003787_abnormal_imprinting | 2.20057325 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.14456337 |
| 25 | MP0001188_hyperpigmentation | 2.13723727 |
| 26 | MP0005671_abnormal_response_to | 2.07939659 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.96783936 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.91261833 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.89654091 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.87827796 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.83143789 |
| 32 | MP0001970_abnormal_pain_threshold | 1.80754436 |
| 33 | MP0002132_abnormal_respiratory_system | 1.80453473 |
| 34 | MP0004924_abnormal_behavior | 1.80366660 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.80366660 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.79062675 |
| 37 | MP0009785_altered_susceptibility_to | 1.78113953 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.77483586 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.77017401 |
| 40 | MP0003075_altered_response_to | 1.74891635 |
| 41 | MP0001853_heart_inflammation | 1.72918151 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.72431890 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.69319277 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.68877075 |
| 45 | MP0001542_abnormal_bone_strength | 1.68239032 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.67242264 |
| 47 | MP0005408_hypopigmentation | 1.64742903 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.64453652 |
| 49 | MP0002184_abnormal_innervation | 1.64372007 |
| 50 | MP0005409_darkened_coat_color | 1.63028028 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.61848715 |
| 52 | MP0008569_lethality_at_weaning | 1.58355729 |
| 53 | MP0001905_abnormal_dopamine_level | 1.56950348 |
| 54 | MP0000685_abnormal_immune_system | 1.55286753 |
| 55 | MP0000778_abnormal_nervous_system | 1.53427984 |
| 56 | MP0001984_abnormal_olfaction | 1.48092214 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.46722782 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.46461017 |
| 59 | MP0009840_abnormal_foam_cell | 1.46401669 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.43503919 |
| 61 | MP0005451_abnormal_body_composition | 1.40254595 |
| 62 | MP0001790_abnormal_immune_system | 1.40034969 |
| 63 | MP0005387_immune_system_phenotype | 1.40034969 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.38708614 |
| 65 | MP0003436_decreased_susceptibility_to | 1.38296310 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.37717003 |
| 67 | MP0003786_premature_aging | 1.37352335 |
| 68 | MP0003123_paternal_imprinting | 1.37085993 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.35330231 |
| 70 | MP0002066_abnormal_motor_capabilities/c | 1.33833896 |
| 71 | MP0000955_abnormal_spinal_cord | 1.31777818 |
| 72 | MP0005025_abnormal_response_to | 1.31472216 |
| 73 | MP0005083_abnormal_biliary_tract | 1.30122336 |
| 74 | MP0003879_abnormal_hair_cell | 1.29900402 |
| 75 | MP0000604_amyloidosis | 1.29602942 |
| 76 | MP0002163_abnormal_gland_morphology | 1.28486247 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.27646289 |
| 78 | MP0005332_abnormal_amino_acid | 1.25472193 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 1.24774035 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.22203841 |
| 81 | MP0008058_abnormal_DNA_repair | 1.20804001 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 1.20729887 |
| 83 | MP0002723_abnormal_immune_serum | 1.19273031 |
| 84 | MP0004142_abnormal_muscle_tone | 1.18039295 |
| 85 | MP0000343_altered_response_to | 1.17662514 |
| 86 | MP0003122_maternal_imprinting | 1.17171274 |
| 87 | MP0000358_abnormal_cell_content/ | 1.16918074 |
| 88 | MP0004147_increased_porphyrin_level | 1.16909460 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.16105167 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.15427555 |
| 91 | MP0008872_abnormal_physiological_respon | 1.15388804 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.15258642 |
| 93 | MP0006292_abnormal_olfactory_placode | 1.14473211 |
| 94 | MP0001881_abnormal_mammary_gland | 1.14180893 |
| 95 | MP0002876_abnormal_thyroid_physiology | 1.12593277 |
| 96 | MP0001819_abnormal_immune_cell | 1.12580833 |
| 97 | MP0005166_decreased_susceptibility_to | 1.12471444 |
| 98 | MP0005165_increased_susceptibility_to | 1.11461605 |
| 99 | MP0002152_abnormal_brain_morphology | 1.09636547 |
| 100 | MP0001800_abnormal_humoral_immune | 1.09604745 |
| 101 | MP0008873_increased_physiological_sensi | 1.09542752 |
| 102 | MP0008260_abnormal_autophagy | 1.09282639 |
| 103 | MP0000678_abnormal_parathyroid_gland | 1.09239719 |
| 104 | MP0003121_genomic_imprinting | 1.08672984 |
| 105 | MP0001845_abnormal_inflammatory_respons | 1.06813551 |
| 106 | MP0002229_neurodegeneration | 1.05204393 |
| 107 | MP0004019_abnormal_vitamin_homeostasis | 1.04239639 |
| 108 | MP0003866_abnormal_defecation | 1.02959513 |
| 109 | MP0008007_abnormal_cellular_replicative | 1.02741858 |
| 110 | MP0004233_abnormal_muscle_weight | 1.02503317 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.02074074 |
| 112 | MP0001986_abnormal_taste_sensitivity | 1.00907314 |
| 113 | MP0005379_endocrine/exocrine_gland_phen | 0.99380076 |
| 114 | MP0005310_abnormal_salivary_gland | 0.97318208 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.96431748 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.96413082 |
| 117 | MP0008469_abnormal_protein_level | 0.96012856 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.95105588 |
| 119 | MP0005499_abnormal_olfactory_system | 0.95105588 |
| 120 | MP0003329_amyloid_beta_deposits | 0.94032081 |
| 121 | MP0005645_abnormal_hypothalamus_physiol | 0.93592440 |
| 122 | MP0006082_CNS_inflammation | 0.92555126 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.91424875 |
| 124 | MP0003633_abnormal_nervous_system | 0.91417036 |
| 125 | MP0003631_nervous_system_phenotype | 0.90075547 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89623461 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.89220717 |
| 128 | MP0004858_abnormal_nervous_system | 0.88404253 |
| 129 | MP0003763_abnormal_thymus_physiology | 0.87576703 |
| 130 | MP0005410_abnormal_fertilization | 0.87122159 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.86551503 |
| 132 | MP0002419_abnormal_innate_immunity | 0.86223649 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.86058999 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.85971515 |
| 135 | MP0000490_abnormal_crypts_of | 0.85707350 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.85432386 |
| 137 | MP0004885_abnormal_endolymph | 0.83934696 |
| 138 | MP0005670_abnormal_white_adipose | 0.82286480 |
| 139 | MP0005253_abnormal_eye_physiology | 0.81608512 |
| 140 | MP0002160_abnormal_reproductive_system | 0.80700863 |
| 141 | MP0002398_abnormal_bone_marrow | 0.80420544 |
| 142 | MP0003693_abnormal_embryo_hatching | 0.80139005 |
| 143 | MP0004085_abnormal_heartbeat | 0.79804914 |
| 144 | MP0006072_abnormal_retinal_apoptosis | 0.77630573 |
| 145 | MP0001756_abnormal_urination | 0.77129189 |
| 146 | MP0004215_abnormal_myocardial_fiber | 0.77095644 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.76942216 |
| 148 | MP0000749_muscle_degeneration | 0.76779927 |
| 149 | MP0000689_abnormal_spleen_morphology | 0.75840735 |
| 150 | MP0001177_atelectasis | 0.75829334 |
| 151 | MP0001533_abnormal_skeleton_physiology | 0.75315080 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.74813887 |
| 153 | MP0004145_abnormal_muscle_electrophysio | 0.74464879 |
| 154 | MP0002638_abnormal_pupillary_reflex | 0.73282405 |
| 155 | MP0008874_decreased_physiological_sensi | 0.71468742 |
| 156 | MP0003632_abnormal_nervous_system | 0.71265008 |
| 157 | MP0010094_abnormal_chromosome_stability | 0.71022697 |
| 158 | MP0003861_abnormal_nervous_system | 0.69087448 |
| 159 | MP0010386_abnormal_urinary_bladder | 0.67813456 |
| 160 | MP0004742_abnormal_vestibular_system | 0.67301239 |
| 161 | MP0002090_abnormal_vision | 0.67070405 |
| 162 | MP0001485_abnormal_pinna_reflex | 0.65569766 |
| 163 | MP0003698_abnormal_male_reproductive | 0.64449824 |
| 164 | MP0005171_absent_coat_pigmentation | 0.63917080 |
| 165 | MP0003646_muscle_fatigue | 0.63171376 |
| 166 | MP0000751_myopathy | 0.62128636 |
| 167 | MP0005623_abnormal_meninges_morphology | 0.61859060 |
| 168 | MP0003137_abnormal_impulse_conducting | 0.58354415 |
| 169 | MP0002751_abnormal_autonomic_nervous | 0.58040446 |
| 170 | MP0001664_abnormal_digestion | 0.56770939 |
| 171 | MP0000569_abnormal_digit_pigmentation | 0.56540050 |
| 172 | MP0002102_abnormal_ear_morphology | 0.56119114 |
| 173 | MP0004484_altered_response_of | 0.54971334 |
| 174 | MP0001943_abnormal_respiration | 0.54843515 |
| 175 | MP0003111_abnormal_nucleus_morphology | 0.53937152 |
| 176 | MP0010769_abnormal_survival | 0.52903692 |
| 177 | MP0002653_abnormal_ependyma_morphology | 0.52495195 |
| 178 | MP0003634_abnormal_glial_cell | 0.51890773 |
| 179 | MP0010770_preweaning_lethality | 0.51770708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.29372540 |
| 2 | Myokymia (HP:0002411) | 6.43742403 |
| 3 | Focal seizures (HP:0007359) | 4.98991624 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.92537798 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.71943522 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.68711934 |
| 7 | Acute encephalopathy (HP:0006846) | 4.45484378 |
| 8 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.34551007 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.27587184 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.27587184 |
| 11 | Febrile seizures (HP:0002373) | 4.20365043 |
| 12 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.18539885 |
| 13 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.18539885 |
| 14 | Increased CSF lactate (HP:0002490) | 4.17151445 |
| 15 | Visual hallucinations (HP:0002367) | 4.15919861 |
| 16 | Hepatocellular necrosis (HP:0001404) | 4.01170843 |
| 17 | Atonic seizures (HP:0010819) | 4.00710864 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.98542772 |
| 19 | Hepatic necrosis (HP:0002605) | 3.90471285 |
| 20 | Increased hepatocellular lipid droplets (HP:0006565) | 3.87792855 |
| 21 | Absence seizures (HP:0002121) | 3.83473172 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.82526333 |
| 23 | Abnormal ciliary motility (HP:0012262) | 3.78223117 |
| 24 | Rhinitis (HP:0012384) | 3.73204689 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.68523390 |
| 26 | Broad-based gait (HP:0002136) | 3.63997412 |
| 27 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.54834053 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 3.54834053 |
| 29 | Dialeptic seizures (HP:0011146) | 3.53542956 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.41515817 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 3.35330754 |
| 32 | Hyperventilation (HP:0002883) | 3.32926446 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.31407859 |
| 34 | Exercise intolerance (HP:0003546) | 3.28889037 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.26066196 |
| 36 | Cerebral edema (HP:0002181) | 3.23191778 |
| 37 | Increased muscle lipid content (HP:0009058) | 3.21499226 |
| 38 | Generalized tonic-clonic seizures (HP:0002069) | 3.17639269 |
| 39 | Increased serum pyruvate (HP:0003542) | 3.14246476 |
| 40 | Lactic acidosis (HP:0003128) | 3.11347121 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 3.03462999 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00865843 |
| 43 | Poor eye contact (HP:0000817) | 3.00773826 |
| 44 | Dysdiadochokinesis (HP:0002075) | 2.94286853 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.93303298 |
| 46 | Chronic bronchitis (HP:0004469) | 2.89137215 |
| 47 | Truncal ataxia (HP:0002078) | 2.88947201 |
| 48 | Abnormality of the labia minora (HP:0012880) | 2.85862713 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.82038680 |
| 50 | Action tremor (HP:0002345) | 2.81501282 |
| 51 | Cerebral hypomyelination (HP:0006808) | 2.81123048 |
| 52 | Bronchiectasis (HP:0002110) | 2.78985295 |
| 53 | Respiratory failure (HP:0002878) | 2.77897973 |
| 54 | Increased serum lactate (HP:0002151) | 2.75829868 |
| 55 | Nasal polyposis (HP:0100582) | 2.73069330 |
| 56 | Anxiety (HP:0000739) | 2.67142077 |
| 57 | Depression (HP:0000716) | 2.58825753 |
| 58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.58734622 |
| 59 | Chronic sinusitis (HP:0011109) | 2.58434925 |
| 60 | Exertional dyspnea (HP:0002875) | 2.58412995 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.57260201 |
| 62 | Scanning speech (HP:0002168) | 2.53074798 |
| 63 | Genetic anticipation (HP:0003743) | 2.51959651 |
| 64 | Impaired social interactions (HP:0000735) | 2.51826006 |
| 65 | Abnormal social behavior (HP:0012433) | 2.51826006 |
| 66 | Limb dystonia (HP:0002451) | 2.49809159 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.48423881 |
| 68 | Macrocytic anemia (HP:0001972) | 2.47670037 |
| 69 | Dysmetria (HP:0001310) | 2.47563494 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.47496893 |
| 71 | Excessive salivation (HP:0003781) | 2.44495800 |
| 72 | Drooling (HP:0002307) | 2.44495800 |
| 73 | Ankle clonus (HP:0011448) | 2.43802627 |
| 74 | Annular pancreas (HP:0001734) | 2.42106546 |
| 75 | Amblyopia (HP:0000646) | 2.37437374 |
| 76 | Leukodystrophy (HP:0002415) | 2.33202304 |
| 77 | Gait imbalance (HP:0002141) | 2.32813709 |
| 78 | Abnormality of placental membranes (HP:0011409) | 2.32568429 |
| 79 | Amniotic constriction ring (HP:0009775) | 2.32568429 |
| 80 | Mutism (HP:0002300) | 2.29449165 |
| 81 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26456707 |
| 82 | Abnormality of renal resorption (HP:0011038) | 2.23442980 |
| 83 | Urinary urgency (HP:0000012) | 2.20592487 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.19982003 |
| 85 | Abnormal hair whorl (HP:0010721) | 2.19315724 |
| 86 | Hyperphosphaturia (HP:0003109) | 2.18815982 |
| 87 | Abnormal eating behavior (HP:0100738) | 2.18052522 |
| 88 | Fetal akinesia sequence (HP:0001989) | 2.17130884 |
| 89 | Respiratory difficulties (HP:0002880) | 2.16488150 |
| 90 | Termporal pattern (HP:0011008) | 2.15006767 |
| 91 | Insidious onset (HP:0003587) | 2.15006767 |
| 92 | Progressive inability to walk (HP:0002505) | 2.14864320 |
| 93 | Inability to walk (HP:0002540) | 2.14862954 |
| 94 | Emotional lability (HP:0000712) | 2.14515658 |
| 95 | Absent speech (HP:0001344) | 2.14380711 |
| 96 | Rough bone trabeculation (HP:0100670) | 2.13875400 |
| 97 | Recurrent sinusitis (HP:0011108) | 2.13151941 |
| 98 | Bradykinesia (HP:0002067) | 2.11707274 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 2.10607940 |
| 100 | Stereotypic behavior (HP:0000733) | 2.10495232 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 2.10288390 |
| 102 | Resting tremor (HP:0002322) | 2.08754437 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 2.08453858 |
| 104 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.07805941 |
| 105 | Torticollis (HP:0000473) | 2.07313359 |
| 106 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.06722294 |
| 107 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05269467 |
| 108 | Abnormality of the lower motor neuron (HP:0002366) | 2.05086075 |
| 109 | Postural instability (HP:0002172) | 2.03032475 |
| 110 | Congenital primary aphakia (HP:0007707) | 2.03004154 |
| 111 | Central scotoma (HP:0000603) | 2.02909242 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 2.02803926 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02803926 |
| 114 | Lethargy (HP:0001254) | 2.02755811 |
| 115 | Focal dystonia (HP:0004373) | 2.01613604 |
| 116 | Dysmetric saccades (HP:0000641) | 2.01521232 |
| 117 | Spastic gait (HP:0002064) | 2.00222141 |
| 118 | Pheochromocytoma (HP:0002666) | 2.00108670 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 2.00080855 |
| 120 | Medial flaring of the eyebrow (HP:0010747) | 1.97777741 |
| 121 | Glycosuria (HP:0003076) | 1.97120969 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.97120969 |
| 123 | Infertility (HP:0000789) | 1.96669856 |
| 124 | Hypertensive crisis (HP:0100735) | 1.95745891 |
| 125 | Bronchitis (HP:0012387) | 1.95615813 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95390188 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95390188 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95390188 |
| 129 | Hemiparesis (HP:0001269) | 1.94906089 |
| 130 | Abnormality of macular pigmentation (HP:0008002) | 1.94601621 |
| 131 | Aplastic anemia (HP:0001915) | 1.92952606 |
| 132 | Pointed chin (HP:0000307) | 1.92743284 |
| 133 | Impaired vibratory sensation (HP:0002495) | 1.92225601 |
| 134 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92120019 |
| 135 | Abnormal number of erythroid precursors (HP:0012131) | 1.91378113 |
| 136 | Incomplete penetrance (HP:0003829) | 1.91046802 |
| 137 | Shoulder girdle muscle weakness (HP:0003547) | 1.87469496 |
| 138 | CNS demyelination (HP:0007305) | 1.87403019 |
| 139 | Posterior subcapsular cataract (HP:0007787) | 1.86712894 |
| 140 | Type I transferrin isoform profile (HP:0003642) | 1.86281813 |
| 141 | Abnormality of binocular vision (HP:0011514) | 1.86223289 |
| 142 | Diplopia (HP:0000651) | 1.86223289 |
| 143 | Methylmalonic acidemia (HP:0002912) | 1.85714333 |
| 144 | Protruding tongue (HP:0010808) | 1.84935429 |
| 145 | Delusions (HP:0000746) | 1.84667952 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83887330 |
| 147 | Progressive microcephaly (HP:0000253) | 1.83529175 |
| 148 | Petechiae (HP:0000967) | 1.82149696 |
| 149 | Horizontal nystagmus (HP:0000666) | 1.82071183 |
| 150 | Hypokinesia (HP:0002375) | 1.81640826 |
| 151 | Unsteady gait (HP:0002317) | 1.80881067 |
| 152 | Acute necrotizing encephalopathy (HP:0006965) | 1.80842564 |
| 153 | Craniofacial dystonia (HP:0012179) | 1.80083370 |
| 154 | Gastroesophageal reflux (HP:0002020) | 1.79960922 |
| 155 | Reticulocytopenia (HP:0001896) | 1.78994913 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.77853391 |
| 157 | Poor suck (HP:0002033) | 1.76746560 |
| 158 | Amyotrophic lateral sclerosis (HP:0007354) | 1.76548771 |
| 159 | Hypsarrhythmia (HP:0002521) | 1.75599314 |
| 160 | Papilledema (HP:0001085) | 1.75380874 |
| 161 | Pancytopenia (HP:0001876) | 1.75302333 |
| 162 | X-linked dominant inheritance (HP:0001423) | 1.75084024 |
| 163 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73833081 |
| 164 | Obstructive lung disease (HP:0006536) | 1.73833081 |
| 165 | Testicular atrophy (HP:0000029) | 1.72544950 |
| 166 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72249690 |
| 167 | Abnormality of alanine metabolism (HP:0010916) | 1.72249690 |
| 168 | Hyperalaninemia (HP:0003348) | 1.72249690 |
| 169 | Recurrent otitis media (HP:0000403) | 1.71863238 |
| 170 | Generalized myoclonic seizures (HP:0002123) | 1.71053639 |
| 171 | Obstructive sleep apnea (HP:0002870) | 1.70901291 |
| 172 | Neuroendocrine neoplasm (HP:0100634) | 1.70711729 |
| 173 | Opisthotonus (HP:0002179) | 1.69962086 |
| 174 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69869671 |
| 175 | Scotoma (HP:0000575) | 1.69637169 |
| 176 | Specific learning disability (HP:0001328) | 1.68556548 |
| 177 | Agammaglobulinemia (HP:0004432) | 1.68526672 |
| 178 | Oral leukoplakia (HP:0002745) | 1.68253775 |
| 179 | Oligomenorrhea (HP:0000876) | 1.67565608 |
| 180 | Methylmalonic aciduria (HP:0012120) | 1.66549438 |
| 181 | Gait ataxia (HP:0002066) | 1.66113029 |
| 182 | Abnormality of the corticospinal tract (HP:0002492) | 1.66012363 |
| 183 | Abnormality of salivation (HP:0100755) | 1.64941535 |
| 184 | Inappropriate behavior (HP:0000719) | 1.61836981 |
| 185 | Progressive macrocephaly (HP:0004481) | 1.61797384 |
| 186 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.60667199 |
| 187 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.60647229 |
| 188 | Severe visual impairment (HP:0001141) | 1.58235678 |
| 189 | Sleep apnea (HP:0010535) | 1.58077897 |
| 190 | Optic disc pallor (HP:0000543) | 1.56935399 |
| 191 | Genital tract atresia (HP:0001827) | 1.56769547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.88161872 |
| 2 | NTRK3 | 4.05628945 |
| 3 | TESK1 | 3.68670382 |
| 4 | NME2 | 3.42130974 |
| 5 | VRK2 | 3.27074883 |
| 6 | CASK | 3.10254516 |
| 7 | LIMK1 | 3.07422212 |
| 8 | TESK2 | 2.95729140 |
| 9 | MST4 | 2.94508127 |
| 10 | STK16 | 2.90360647 |
| 11 | MAP3K9 | 2.85336093 |
| 12 | MAP3K4 | 2.72003078 |
| 13 | MINK1 | 2.62010483 |
| 14 | MAP2K7 | 2.61684434 |
| 15 | PIM2 | 2.61196402 |
| 16 | MARK1 | 2.58162992 |
| 17 | BCKDK | 2.51089397 |
| 18 | SCYL2 | 2.33186162 |
| 19 | PLK2 | 2.23722613 |
| 20 | RIPK4 | 2.09633384 |
| 21 | BUB1 | 2.06216180 |
| 22 | PNCK | 1.96654491 |
| 23 | DAPK2 | 1.91054273 |
| 24 | MAP3K12 | 1.87967052 |
| 25 | DAPK1 | 1.83257489 |
| 26 | MAP3K11 | 1.62925393 |
| 27 | MYLK | 1.62599966 |
| 28 | PAK6 | 1.59264979 |
| 29 | KSR1 | 1.57164968 |
| 30 | MAP3K3 | 1.54704183 |
| 31 | TSSK6 | 1.54446686 |
| 32 | PRKD3 | 1.52359177 |
| 33 | TAOK2 | 1.51701951 |
| 34 | CDK19 | 1.51693592 |
| 35 | MAPKAPK3 | 1.48393713 |
| 36 | FES | 1.46709947 |
| 37 | EIF2AK1 | 1.44182500 |
| 38 | ARAF | 1.40636255 |
| 39 | CCNB1 | 1.39480033 |
| 40 | EIF2AK3 | 1.37321587 |
| 41 | CDK5 | 1.35981953 |
| 42 | KSR2 | 1.35831717 |
| 43 | MAPK13 | 1.35288522 |
| 44 | CDC7 | 1.35149148 |
| 45 | NME1 | 1.34098662 |
| 46 | ABL2 | 1.33821374 |
| 47 | PBK | 1.31460902 |
| 48 | NEK1 | 1.31322041 |
| 49 | GRK5 | 1.29679425 |
| 50 | KDR | 1.28628096 |
| 51 | TNIK | 1.27116441 |
| 52 | AKT3 | 1.26910781 |
| 53 | CAMKK1 | 1.25575406 |
| 54 | TBK1 | 1.24998553 |
| 55 | MAP2K4 | 1.22926648 |
| 56 | PRKCG | 1.22048950 |
| 57 | DAPK3 | 1.21987355 |
| 58 | NTRK2 | 1.21228504 |
| 59 | PRPF4B | 1.20925529 |
| 60 | ILK | 1.18881449 |
| 61 | CDK18 | 1.17699536 |
| 62 | CDK14 | 1.12183310 |
| 63 | CDK15 | 1.10120816 |
| 64 | LRRK2 | 1.00814861 |
| 65 | STK38 | 1.00441142 |
| 66 | SIK3 | 0.99672654 |
| 67 | AURKA | 0.98598499 |
| 68 | PAK4 | 0.98030167 |
| 69 | CDK11A | 0.97637405 |
| 70 | PLK3 | 0.96523442 |
| 71 | SGK2 | 0.96170934 |
| 72 | PAK1 | 0.93193939 |
| 73 | CAMK2A | 0.89554407 |
| 74 | BRAF | 0.89303924 |
| 75 | MKNK2 | 0.86264143 |
| 76 | SGK223 | 0.85426510 |
| 77 | SGK494 | 0.85426510 |
| 78 | NTRK1 | 0.85362577 |
| 79 | TLK1 | 0.82447495 |
| 80 | CAMK2G | 0.81981267 |
| 81 | BMPR2 | 0.81560803 |
| 82 | PASK | 0.81170907 |
| 83 | TXK | 0.80011090 |
| 84 | IKBKE | 0.78939396 |
| 85 | PDK2 | 0.77880786 |
| 86 | BRSK1 | 0.77667845 |
| 87 | MAP2K3 | 0.77624380 |
| 88 | SIK2 | 0.77268117 |
| 89 | CAMK2B | 0.76223733 |
| 90 | PRKCI | 0.75573698 |
| 91 | RAF1 | 0.75263678 |
| 92 | CAMKK2 | 0.75214499 |
| 93 | PINK1 | 0.72673487 |
| 94 | PTK2B | 0.71831302 |
| 95 | GRK6 | 0.71465748 |
| 96 | BCR | 0.71289849 |
| 97 | TAOK1 | 0.70360414 |
| 98 | LATS2 | 0.69547059 |
| 99 | OXSR1 | 0.68673327 |
| 100 | DYRK1A | 0.67797837 |
| 101 | ALK | 0.66694722 |
| 102 | IKBKB | 0.66606068 |
| 103 | MAP4K1 | 0.65872652 |
| 104 | MOS | 0.65154621 |
| 105 | SGK1 | 0.64480971 |
| 106 | VRK1 | 0.63523065 |
| 107 | MAP3K13 | 0.62073106 |
| 108 | SGK3 | 0.61244449 |
| 109 | UHMK1 | 0.59931425 |
| 110 | SMG1 | 0.57796527 |
| 111 | PRKCD | 0.57594566 |
| 112 | CAMK1 | 0.56601225 |
| 113 | TYRO3 | 0.56267023 |
| 114 | CSNK2A2 | 0.54817554 |
| 115 | FGR | 0.53509834 |
| 116 | STK11 | 0.53341025 |
| 117 | MAP4K2 | 0.52976788 |
| 118 | PRKCQ | 0.52949459 |
| 119 | NEK9 | 0.49933837 |
| 120 | TYK2 | 0.48113470 |
| 121 | CSNK1G2 | 0.47593273 |
| 122 | PDK4 | 0.46829829 |
| 123 | PDK3 | 0.46829829 |
| 124 | CSNK2A1 | 0.46167373 |
| 125 | AKT2 | 0.45597416 |
| 126 | PHKG2 | 0.45439342 |
| 127 | PHKG1 | 0.45439342 |
| 128 | CSNK1E | 0.45304876 |
| 129 | PDK1 | 0.44393917 |
| 130 | SYK | 0.43765530 |
| 131 | PRKCH | 0.43568177 |
| 132 | MKNK1 | 0.43275366 |
| 133 | RPS6KA3 | 0.43175354 |
| 134 | DYRK2 | 0.41695605 |
| 135 | PRKCB | 0.40979119 |
| 136 | WEE1 | 0.40229870 |
| 137 | MAPK10 | 0.40183776 |
| 138 | ADRBK1 | 0.39751643 |
| 139 | PLK1 | 0.38810430 |
| 140 | CDK8 | 0.38665091 |
| 141 | MAPK15 | 0.38597316 |
| 142 | NEK6 | 0.38353824 |
| 143 | CSNK1G3 | 0.37842751 |
| 144 | PRKCE | 0.37439537 |
| 145 | CAMK2D | 0.35658208 |
| 146 | STK10 | 0.35273296 |
| 147 | PRKG2 | 0.34652847 |
| 148 | GRK7 | 0.32379666 |
| 149 | ROCK2 | 0.31697515 |
| 150 | FYN | 0.31278520 |
| 151 | FER | 0.31263666 |
| 152 | GSK3B | 0.31201900 |
| 153 | PDPK1 | 0.30535172 |
| 154 | PRKCA | 0.30243057 |
| 155 | LMTK2 | 0.29757119 |
| 156 | PRKACA | 0.29515027 |
| 157 | CSNK1A1 | 0.29496111 |
| 158 | CDK9 | 0.28609936 |
| 159 | SRPK1 | 0.26766621 |
| 160 | IRAK3 | 0.26403931 |
| 161 | MAPKAPK2 | 0.26238932 |
| 162 | TRIM28 | 0.25960155 |
| 163 | MAP3K5 | 0.25759100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.23773970 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83254577 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42488576 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.02718092 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.75324174 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.66917999 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63256635 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.62139506 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60547130 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58273125 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57677118 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.56725951 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.52172274 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39811645 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35709885 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.99521954 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86014628 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81045532 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.79379334 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.76697366 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.75107808 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72860892 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.70296877 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68772550 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68027163 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58876576 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58508970 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58138091 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55989463 |
| 30 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.53932423 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.51945236 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51555654 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50243360 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47802128 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42491531 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37253636 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.34742940 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.34522691 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34401168 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34247541 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34200829 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34162035 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29646139 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29258140 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28186336 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25156261 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23628479 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22072038 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20962655 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18999306 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18261840 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.16593781 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16098488 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12117079 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10253493 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.09362796 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03068156 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02146110 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01339506 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01200319 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00078962 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95588951 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.95294098 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93525376 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.92391854 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.91582728 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.90895747 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.90449147 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90166276 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90111406 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.88032364 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87261066 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85329451 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82934846 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82832334 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80219155 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77147225 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76955209 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76542796 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76500333 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75359167 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74845454 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74443386 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74300456 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.70163462 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69782201 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68312099 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66813179 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.66370807 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65295908 |
| 91 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63178530 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63008523 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.61641320 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60789090 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60716632 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.59510048 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59490967 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.58371319 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58182329 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58134744 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58010244 |
| 102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57271510 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55884301 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.55219570 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54238992 |
| 106 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54090942 |
| 107 | Homologous recombination_Homo sapiens_hsa03440 | 0.53143622 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52327125 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52217102 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.51720973 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51375346 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.50838975 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50524343 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50458371 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50399221 |
| 116 | RNA polymerase_Homo sapiens_hsa03020 | 0.50285278 |
| 117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49949787 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49019731 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48210760 |
| 120 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47627646 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47527824 |
| 122 | RNA transport_Homo sapiens_hsa03013 | 0.45549949 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | 0.45450474 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45267243 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44864831 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44636946 |
| 127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43866846 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43266915 |
| 129 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43213203 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41677826 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41644531 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40716092 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39827408 |
| 134 | Spliceosome_Homo sapiens_hsa03040 | 0.39108193 |
| 135 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39060281 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38193267 |
| 137 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37208116 |
| 138 | Cell cycle_Homo sapiens_hsa04110 | 0.36928189 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36491751 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.36319341 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36088995 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34807959 |
| 143 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.33998282 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.33791055 |
| 145 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33534819 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33363926 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33073763 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32074739 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30754435 |
| 150 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30433949 |
| 151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29892009 |
| 152 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28857600 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28782092 |
| 154 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28216945 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28033999 |
| 156 | Mismatch repair_Homo sapiens_hsa03430 | 0.27928872 |
| 157 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27877692 |
| 158 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27645853 |
| 159 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27394691 |
| 160 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26908914 |
| 161 | Melanoma_Homo sapiens_hsa05218 | 0.26631141 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26576752 |
| 163 | DNA replication_Homo sapiens_hsa03030 | 0.26488714 |
| 164 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26304837 |
| 165 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25180325 |
| 166 | Mineral absorption_Homo sapiens_hsa04978 | 0.24953616 |
| 167 | Viral myocarditis_Homo sapiens_hsa05416 | 0.24219564 |
| 168 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22596183 |
| 169 | Prion diseases_Homo sapiens_hsa05020 | 0.21492784 |
| 170 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21329434 |
| 171 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15770448 |
| 172 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.10495312 |

